The ubiquitously expressed cystatin C has received more attention in the realm of neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and MS, for its inhibitory effect on cathepsin B [57–59]. This evidence concerns the gene CTSB and early-onset autosomal dominant Alzheimer disease.